The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Abiraterone decanoate (PRL-02): Pharmacology of a single intramuscular (IM) depot injection compared to oral abiraterone acetate (AA) in intact male rats.
 
William R. Moore
Employment - Propella Therapeutics; Vizuri
Leadership - Propella Therapeutics; Vizuri
Stock and Other Ownership Interests - Propella Therapeutics; Vizuri
Research Funding - Propella Therapeutics; Vizuri
Patents, Royalties, Other Intellectual Property - I'm an inventor on patents that were assigned to Propella Therapeutics that protect composition of matter, methods of use, and manufacturing of abiraterone decanoate
Travel, Accommodations, Expenses - Propella Therapeutics; Vizuri
 
Matthew Sharp
Employment - Propella Therapeutics; Vizuri
Stock and Other Ownership Interests - Propella Therapeutics
Patents, Royalties, Other Intellectual Property - Patent applications in progress with Propella Therapeutics
Travel, Accommodations, Expenses - Propella Therapeutics
 
Joel Robert Eisner
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric; Innocrin Pharma
Consulting or Advisory Role - Propella Therapeutics
Patents, Royalties, Other Intellectual Property - Provisional patents for GeneCentric and Innocrin Pharma as part of my employments
 
Caroline Bell
Stock and Other Ownership Interests - Multiple
Consulting or Advisory Role - Propella Therapeutics (Inst); Vizuri (Inst)
 
Stuart Freeman
Consulting or Advisory Role - GlaxoSmithKline UK Ltd.
 
Tony Leesnitzer
Employment - IQVIA (I); OpAns
Stock and Other Ownership Interests - GlaxoSmithKline; GlaxoSmithKline (I)
 
Robert Schotzinger
Leadership - Arrevus; Mycovia Pharmaceuticals; Propella Therapeutics
Stock and Other Ownership Interests - Arrevus; Propella Therapeutics
Consulting or Advisory Role - Arrevus; Mycovia Pharmaceuticals; Propella Therapeutics